NCT06216002 Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery
| NCT ID | NCT06216002 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mahidol University |
| Condition | Frailty |
| Study Type | INTERVENTIONAL |
| Enrollment | 622 participants |
| Start Date | 2024-01-02 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 622 participants in total. It began in 2024-01-02 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Frailty among patients undergoing surgery is strongly associated with an elevated risk of adverse perioperative outcomes, heightened incidence of postoperative complications, increased mortality rates, and prolonged hospital length of stay. Our focus centers on investigating the frailty index in the context of complications experienced by patients undergoing oncologic gynecology surgery. The principal objective of this research is to elucidate the extent to which residual neuromuscular blocking agents are linked to frailty.
Eligibility Criteria
Inclusion Criteria: * Age \>,= 18 years * Patients undergoing elective gynecologic-oncology surgery Exclusion Criteria: * Unable to communicate Thai * Unable to understand the questionnaire * Preexisting neuromuscular disease * Preexisting disease involved wrist that may affect the nerve stimulator examination
Contact & Investigator
Patchareya Nivatpumin, M.D.
STUDY DIRECTOR
Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University
Frequently Asked Questions
Who can join the NCT06216002 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Frailty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06216002 currently recruiting?
Yes, NCT06216002 is actively recruiting participants. Contact the research team at patchareya.niv@mahidol.ac.th for enrollment information.
Where is the NCT06216002 trial being conducted?
This trial is being conducted at Bangkok, Thailand.
Who is sponsoring the NCT06216002 clinical trial?
NCT06216002 is sponsored by Mahidol University. The principal investigator is Patchareya Nivatpumin, M.D. at Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University. The trial plans to enroll 622 participants.